According to a study published in JAMA Dermatology, less than 60% of US patients with chronic inflammatory disease (CISD) receive the requisite testing before beginning systemic immunomodulatory treatment. Doctors recommend laboratory resting for the presence of tuberculosis, hepatitis, and other conditions before starting most systemic immunomodulatory agents in patients with chronic inflammatory skin diseases. However, the current testing patterns in the US are unclear. ...
Disparities in Hidradenitis Suppurativa
Advertisement
Julia Riley, MD, of Northwestern Medicine, goes in depth on racial disparities in hidradenitis suppurativa.
Dr. Adam Friedman talks about a telemedicine program designed to improve dermatologic medical care in underserved areas.
There exists a link between self-management-competency and hidradenitis suppurativa.
A study indicates a potential link between hidradenitis suppurativa and dissecting cellulitis.
Individuals with hidradenitis suppurativa face barriers to access dermatology care.
A multitude of factors lead to disparities in the treatment of hidradenitis suppurativa in Black patients.
Hidradenitis suppurativa patients see their comorbidity burden increase following diagnosis.
A study analyzed HS prevalence in Lagos, Nigeria.
Patients with hidradenitis suppurativa have an increased prevalence of anemia.
Psychosocial screenings are low among hidradenitis suppurativa patients.
Advertisement
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
Advertisement
Section Editor
Julia Riley, MDAssistant Professor of Dermatology | Northwestern Feinberg School of Medicine
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.